Continuity Biosciences
PrivateLast Round
Grant
Oct 14, 2026
Total Funding Raised
$13.35M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Continuity Biosciences operates in Healthcare & Life Sciences and is based in Bradenton, Florida. Its latest recorded funding round was a Series A round in June 2025.
Continuity Biosciences is a biotechnology company developing implantable and device-enabled platform technologies for cell reprogramming, immune modulation, and precision drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Continuity Biosciences Comparables
Compare Continuity Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Procyon Technologies LLC | 78% | |
| Encellin | 78% | |
| Persista Bio Inc. | 77% |
For institutional investors. Book with your work email.
Continuity Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 14, 2026 | ||||
| Series A | Jun 12, 2025 | ||||
| Seed | Jun 4, 2025 | ||||
| Seed | Jul 2, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Continuity Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Crocker Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2026
Open roles increased to 5, representing 19% of headcount.
- Oct 14, 2026
Received $9.6M from the Bill & Melinda Gates Foundation.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 14, 2026
On Oct 14th '26, Continuity Biosciences, Inc. receives a grant of up to $9.6M from the Gates Foundation in Florida and Washington to advance a subcutaneous, ultra-long-acting antiretroviral implant for HIV prevention through IND-enabling studies, an IND application, and a Phase 1 first-in-human study.
For institutional investors. Book with your work email.
Continuity Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Continuity Biosciences's valuation, stock price, and market status.
Is Continuity Biosciences a public or private company?
Continuity Biosciences is a private company.
What is the current stock price of Continuity Biosciences?
Continuity Biosciences is a private company, so its shares have no public market price. Caplight tracks Continuity Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Continuity Biosciences worth (valuation)?
Valuation information for Continuity Biosciences is not publicly available.
Can I buy Continuity Biosciences stock?
Continuity Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Continuity Biosciences's last funding round?
Continuity Biosciences's most recent funding round was Grant on October 14, 2026.
Who are the main investors in Continuity Biosciences?
Key investors in Continuity Biosciences include Gates Foundation, Bill & Melinda Gates Foundation, Crocker Ventures.
Will Continuity Biosciences IPO soon?
No public IPO plans have been announced for Continuity Biosciences.
How can I track Continuity Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Continuity Biosciences's shares on secondary markets.